is semaglutide safe with high blood pressure GLP-1 drugs tied to elevated risk of low episodes GLP-1 and Low Blood Pressure:

5 The annual incidence ranges from 8.8 to 23.1 per 100,000 person-years in North America, 0.624.3 per 100,000 person-years in Europe, and 7.317.4 per 100,000 person-years in Oceania, with a prevalence in adults in their 30 s and 40 s

PubMed , International Journal of Environmental Research and Public Health , vol

In 2022, the company that owns the patent of Eriomin funded a small clinical trial involving 45 people, concluding that those who took it over a 12-week period had lower blood glucose and higher GLP-1 than those who took a placebo

The troubleshooting guide for semaglutide notes that overdosing paradoxically can stall weight loss due to the body stress response and inability to maintain adequate nutrition